Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023;10(1):1-4.
doi: 10.14283/jpad.2023.1.

Editorial: Accelerating Innovations for Enhanced Brain Health. Can Artificial Intelligence Advance New Pathways for Drug Discovery for Alzheimer's and other Neurodegenerative Disorders?

Affiliations
Editorial

Editorial: Accelerating Innovations for Enhanced Brain Health. Can Artificial Intelligence Advance New Pathways for Drug Discovery for Alzheimer's and other Neurodegenerative Disorders?

A S Khachaturian et al. J Prev Alzheimers Dis. 2023.
No abstract available

PubMed Disclaimer

References

    1. Van Dyck C, et al. Lecanemab in Early Alzheimer's Disease. N Engl J Med. 2023;388(1):9–21. 10.1056/NEJMoa2212948 PubMed PMID: 36449413, Jan 5. - DOI - PubMed
    1. Sims J, et al. Donanemab in Early Symptomatic Alzheimer Disease. JAMA. 2023;330(6):512–527. 10.1001/jama.2023.13239 PubMed PMID: 37459141, Aug 8. - DOI - PMC - PubMed
    1. Sperling R, et al. Trial of Solanezumab in Preclinical Alzheimer's Disease. N Engl J Med. 2023;389(12):1096–1107. 10.1056/NEJMoa2305032 PubMed PMID: 37458272, Sep 21. - DOI - PMC - PubMed
    1. Salloway S, et al. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. Nat Med. 2021;27(7):1187–1196. 10.1038/s41591-021-01369-8 PubMed PMID: 34155411, PMCID 8988051, Jul. - DOI - PMC - PubMed
    1. Sperling R, et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement. 2011;7(4):367–385. 10.1016/j.jalz.2011.05.2351 PubMed PMID: 21784348, PMCID 3693547, Jul. - DOI - PMC - PubMed

Publication types